To determine whether heparan sulphate residues on the cellular surface could serve as an attachment receptor for pseudorabies virus (PRV), the effect of heparin on PRV in plaque reduction and adsorption tests was investigated. PRV was significantly less sensitive to heparin than was herpes simplex virus type 1 (HSV-1). At concentrations of 500 lag/ml heparin the number of plaques formed by PRV was reduced to 7 % of the untreated control whereas the number of plaques formed by HSV-1 was reduced to below 0.1%. Adsorption of PRV to host cells was also less sensitive to heparin treatment than was adsorption of HSV-1.
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The first events in the life cycte of.a herpesvirus-are attachment to the cellular surface and entry of the virus into the cytoplasm of its host cell. Many studies on the entry of herpesviruses into the cell have been done (Epstein et al., 1964; Morgan et al., 1968; Dales & Silverberg, 1969; Smith & deHarven, 1974; DeLuca et al., 1981; Rosenthal et al., 1989) , but little was known about attachment (Fuller & Spear, 1985; Johnson & Ligas, 1988) until it was shown recently by WuDunn & Spear (1989) that heparan sulphate proteoglycans present on the surface of many cell types (H66k et al., 1984) serve as an attachment receptor for herpes simplex virus (HSV) types 1 and 2. They used heparin, a glycosaminoglycan structurally related to heparan sulphate, to block specifically the attachment of HSV to the cell surface and to reduce the number of plaques formed by HSV on HEp-2 cells.
To determine whether heparan sulphate can also serve as an attachment receptor for pseudorabies virus (PRV), a herpesvirus of swine causing Aujeszky's disease in pigs, the effect of heparin on plaque formation and adsorption of PRV (strain Ka), was evaluated and compared with HSV-I strain HFEM. Fig. 1 shows that heparin inhibited plaque formation (a) and virus adsorption (b) of PRV to RK13 cells, a rabbit kidney cell line. Interestingly, both viruses were affected by heparin treatment, but PRV was significantly less sensitive to heparin than was HSV-1. The number of plaques formed by PRV was reduced to 10~ of the untreated control (100~) by 10 ~g/ml heparin, but could not be reduced below 7 ~ even with concentrations up to 500 gg/ml, whereas the number of plaques formed by HSV-1 on HEp-2 cells was reduced to approximately 1 ~ of the untreated control value by 10 pg/ml heparin and was reduced even further to below 0-1~ with concentrations of 500 I-tg/ml. Adsorption of HSV-1 to HEp-2 cells was reduced to 3 ~o of the untreated control (100~o) by a concentration of up to 500 pg/ml heparin, whereas adsorption of PRV to RK 13 cells was reduced to 45~ of the untreated control. Therefore it can be concluded that either the virus attachment structures of PRV are less sensitive to heparin or that adsorption of PRV can occur in more than one way, as reported by Schreurs et al. (1988) . In the latter case, one method must be insensitive to heparin.
Since viral glycoproteins play a major role in virus attachment and entry (Sarmiento et al., 1979; Little et al., 1980; Fuller & Spear, 1985; Desai et al., 1988 ; Johnson & Ligas, 1988; Schreurs et al., 1988; Johnson & Spear, 1989) we determined which of the PRV glycoproteins have an affinity for heparin. In our experiments, [3H]glucosamine-labelled PRV proteins were bound to heparin-acrylic-beads (HAB) and subsequently analysed in SDS-PAGE and two-dimensional (2D) PAGE. After equilibrating I00 mg of HAB (Sigma) with PBS, 100 gl PBS or PBS containing heparin (2 mg/ml) and 100 gl of [3H]glucosamine-labelled PRV were added and incubated for 120 min on ice. Thereafter the beads were washed seven times with 500 gl NT buffer (50 mM-Tris-HCI pH 7.4, 150 mM-NaC1). After sedimenting the beads and discarding the washing buffer, bound proteins were released from all binding of proteins to the beads (lane 2), demonstrating that the proteins were specifically bound to heparin and not non-specifically to the beads. Reduction of the samples with 0-025 M-dithioerythritol (DTE) had no effect on the 75K band. However, the 150K band is significantly less intense, under reducing conditions, leading to two new proteins with Mr values of 98K and 56K. In addition, the 62K band is broader under these conditions. From these results it can be concluded that the 150K band represents the disulphidelinked glycoprotein complex glI (Hampl et al., 1984;  the beads by incubation with 8 M-urea containing 2% SDS for 5 min at 100 °C. Beads were sedimented by centrifugation for 5 min at 15000g and the supernatant was analysed on a 10% SDS-PAGE gel. Samples in lanes 4 and 5 were reduced by treatment with 0.025 M-DTE. Samples in lanes 1, 2 and 3 are non-reduced. Lanes 1 and 4 (HAB) show that under non-reducing conditions proteins with M~ values of approximately 150K, 75K and 62K were precipitated with HAB. Under reducing conditions the 150K band is smaller and two new proteins with Mr values of 98K and 56K are detectable. Lane 2 (HAB + heparin) shows that no protein bound to HAB when heparin was added to the binding assay at 1 mg/ml. In lanes 3 and 5 the proteins of the whole Tritonsolubilized envelope fraction are demonstrated for comparison. [3H]Glucosamine-labelled PRV proteins were precipitated with HAB as described in Fig. 2 but released from the beads by incubation with lysis buffer (9-5 M-urea, 2 Triton X-100, 1-6 ~ Ampholines pH 5 to 8, 0.4 ~ Ampholines pH 3 to 10, 5 ~ 2-mercaptoethanol) for 30 min at 37 °C. Two-dimensional PAGE was performed as described by O'Farrell (1975) with minor modifications. Gels containing a mixture of 1.6% carrier Ampholines pH 5 to 8 and 0-4% pH 3 to 10 (Pharmacia) were used. Samples were focused for 18 h at 400 V and 1 h at 800 V, yielding 8000 Vh. Focused gels were stored at -70 °C until the second dimension separation was done, on 10~ SDS polyacrylamide gels. Isoelectric focusing (IEF) gels were equilibrated for SDS-PAGE by incubation in SDS equilibration buffer (O'Farrell, 1975) prior to use. The pH gradient in the focused IEF gel was determined with a Beckman pH meter after slicing the gels into 5 mm sections and incubating them in 8 M-urea for 30 min. The gradient usually spanned 2 pH units and ran between pH 6-0 and 8.0. The peptides with M~ values of 123K, 69K and the double row of spots with M, 56K and 58K were identified as glIa, gtlb and glIc. With a n M r of 75K to 100K gill is visible on the right side of the gel. The remaining two spots with Mr values of about 105K and 56K to 71K were identified as glV and gV, respectively. The pH measured in the IEF gel is shown across the top of the gel. Mr markers are shown on the right. Fig. 4 . Two-dimensional PAGE of immunoprecipitated gill.
[3H]Glucosamine-labelled gill was immunoprecipitated with a polyclonal goat serum against a denatured E. coli-produced cro-glIl fusion protein (Ryan et al., 1987) and subsequently analysed in 2D PAGE. Immunoprecipitation was done by the method of Kessler (1975) with the modifications described previously (Hampl et al., 1984) , but Protein A-Sepharose CL-4B (Sigma) was used instead of preparations of Staphylococcus aureus. Two-dimensional PAGE was as described for et. al., 1987) . Although their Mr values would be slightly smaller t h a n those reported previously ( H a m p l et al., 1984) , the 98K b a n d would represent the gIIa peptide and the 56K peptide would be gIIc. gIIb, with an Mr estimated to be about 74K would be represented by the b a n d in the 62K range.
To identify the 150K DTE-sensitive protein as well as the 75K band, P R V proteins b o u n d to H A B were separated by 2D P A G E and identified by c o m p a r i n g their position on the gels with the 2D P A G E analysis of P R V glycoproteins (published by H a m p l et al., 1984) as well as gels of i m m u n o p r e c i p i t a t e d P R V proteins. The three peptides visible in Fig. 3 with M r values of about 123K, 69K and the double row of spots at 56K and 58K could be identified as gIIa, gIIb and gIIc. This proved that the 150K b a n d represents the gII complex. Since 2D P A G E was done u n d e r reducing conditions, no complex was visible.
Little is k n o w n about the biological functions of P R V gII. As gII shows a significant homology on the a m i n o acid level to HSV-1 gB ( R o b b i n s et al., 1987) , it can be concluded that it could serve similar functions. HSV-1 Short communication gB is highly conserved among herpesviruses and gB homologues have also been described for HSV-2 (Person et al., 1985) , human cytomegalovirus (Cranage et al., 1986 ), variceUa-zoster virus (Emini et al., 1987 , bovine herpesvirus type l (Misra et al., 1988) , Epstein-Barr virus (Pellett et al., 1985 a) , Marek's disease virus (Ross et aI., 1989) and equine herpesvirus types 1 and 2 (Meredith et al., 1989; Whalley et al., 1989) . HSV gB has been shown to be involved in virus entry into host cells (Little et al., 1980; Pellett et al., 1985b; Cai et al., 1988; Highlander et al., 1988) and virus-induced cell fusion (Cai et al., 1988) . Since gB-deficient virions were shown to bind to the cellular surface (Sarmiento et al., 1979; Little et al., 1980; Cai et al., 1988; Highlander et al., 1988) , it can be concluded that HSV gB is essential for infectivity at the level of penetration but is not involved in virus attachment to the cell.
As no data are available, concerning the biological functions of PRV glI, no comments about the biological significance of the heparin-binding properties of glI can be made.
The 75K protein could be identified as glII, which is known to be one of the major non-essential glycoproteins of PRV (Robbins et al., 1986b) . It was shown to be homologous to glycoprotein C (gC) of HSV (Wathen & Wathen, 1986; Robbins et al., t986a) . Monoclonal antibodies against gill are able to neutralize virus in the absence of complement (Hampl et al., 1984) ; glII was shown to be important also for stable adsorption of PRV to and entry into host cells (Schreurs et al., 1988) , and for the efficient release of virus from infected cells (Whealy et al., 1988) . Although adsorption of glII-mutants is slower and less efficient than is that of wild-type virus (Schreurs et al., 1988) these mutants are still infectious. Therefore adsorption of PRV to cells can occur by at least one other mechanism. The results from our plaque reduction and adsorption tests suggest that this mechanism cannot be affected by treatment of the virus with heparin, because concentrations up to even 500 p.g/ml heparin were not sufficient to reduce virus adsorption and plaque formation below 45 ~ and 7 ~, respectively, in comparison to the untreated control.
The other two spots on the gel with Mr values of approximately 105K and 56K to 71K can be identified as glycoproteins glV and gV, respectively (Hampl et al., 1984) . As shown in Fig. 4 , we could detect glV on 2D PAGE analyses after immunoprecipitation of gill using a polyclonal goat serum against a denatured Escherichia coli-produced cro-glII fusion protein (Ryan et al., 1987) . Therefore it is evident that glV is antigenically related to gill or to a degradation product of this protein. 
